IA
BEAM icon

IndexIQ Advisors’s Beam Therapeutics BEAM Stock Holding History

IndexIQ Advisors’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,276
Closed -$420K – 1330
2021
Q4 		$420K Sell
5,276
-341
-6% -$29.2K 0.01% 734
2021
Q3 		$489K Buy
5,617
+562
+11% +$56.5K 0.02% 571
2021
Q2 		$651K Sell
5,055
-242
-5% -$19.3K 0.02% 378
2021
Q1 		$424K Buy
+5,297
New +$504K 0.02% 436

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IndexIQ Advisors's BEAM Position: Q1 2022 in Review

IndexIQ Advisors sold out of Beam Therapeutics (BEAM) in Q1 2022, closing a stake of 5,276 shares — an estimated $420K sold.

IndexIQ Advisors first reported a position in BEAM in Q1 2021 and held it in 4 quarters. The position peaked at $651K in Q2 2021. 240 funds tracked by Wall St. Rank hold BEAM as of Q1 2022.

  • IndexIQ Advisors reported no remaining Beam Therapeutics position as of Q1 2022 after selling out during the quarter.
  • IndexIQ Advisors sold 5,276 Beam Therapeutics shares in Q1 2022, an estimated $420K.
  • IndexIQ Advisors first reported a position in Beam Therapeutics in Q1 2021 and held it in 4 quarters.
  • IndexIQ Advisors's Beam Therapeutics position peaked at $651K in Q2 2021.
  • 240 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.